Physician Assistant in Old Town, ME Accepting Medicare

6 Physician Assistant nurses found. Showing 1 - 6

Charles A Roberts, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 242 Brunswick St, Old Town, ME 04468 Phone: 207-827-6128    Fax: 207-827-6605

Olivia J Greer, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 242 Brunswick St, Old Town, ME 04468 Phone: 207-827-6128    Fax: 207-827-6605

Kara A Middleton, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 242 Brunswick St, Old Town, ME 04468 Phone: 207-827-6128    Fax: 207-827-6605

Linda M Christensen, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 242 Brunswick St, Old Town, ME 04468 Phone: 207-827-6128    Fax: 207-827-5533

Jolene R Driver, PAC Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 242 Brunswick St, Old Town, ME 04468 Phone: 207-827-6128    Fax: 207-827-6605

Kay M Nash, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 242 Brunswick St, Old Town, ME 04468 Phone: 207-827-6128    Fax: 207-907-7079

News Archive

New polymer-lipid hybrid nanoparticle

A novel combination of lipids, a negatively charged polymer, and the anticancer drug doxorubicin has yielded a new nanoparticle that can kill breast cancer cells that are normally resistant to this drug.

Purdue Pharma announces agreement to end OxyContin patent lawsuit with Teva Pharmaceuticals

Purdue Pharma L.P. of Stamford, Connecticut and Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania have agreed to end their lawsuit concerning certain Purdue Pharma patents on OxyContin (oxycodone HCl controlled-release) Tablets.

FG-4592 oral anemia therapy receives CTA approval from SFDA

FibroGen, Inc., today announced that its investigational oral anemia therapy, FG-4592, received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to commence clinical development for the treatment of anemia associated with chronic kidney disease (CKD) in the People's Republic of China.

Noveko International to raise funds for pursuing its global growth objectives

Noveko International Inc. ("the Company") is pleased to announce that it has entered into an agreement with Desjardins Securities Inc. as lead Agent on behalf of a syndicate (collectively "the Agents") to raise approximately C$10 million of Units (the "Units") by way of a best efforts private placement (the "Offering"). Each Unit will consist of one Class A Share of the Company and one-half of one Class A Share purchase warrant. The Units will be priced in the context of the market.

Read more Medical News

› Verified 6 days ago